Hair Loss Treatment Products Market Overview
Baldness is a term that refers to a person's scalp losing a lot of hair. The most prevalent cause of baldness is hereditary hair loss as people become older. Some people would rather let their hair loss go unnoticed and untreated. Hair loss can be caused by a variety of factors, and it can also be treated in a variety of ways. Hair loss treatment treatments stop hair loss in its tracks and encourage hair growth.
The major factors driving the hair loss treatment market are changing lifestyle patterns, increasing stress levels due to the adoption of hectic schedules, which results in frequent hair loss at an earlier age among the young population, increasing disposable income, and increasing emphasis on appearance. Hair loss is caused by a variety of factors including heredity, excessive stress or shock to the body, toxic substances such as chemotherapy, radiation therapy, and some drugs, as well as medical disorders.
The global hair loss treatment products market is being boosted by rising demand for hair loss treatment products, an increase in patient population, an increase in research and development activities in health care, an increase in the geriatric population, and an increase in the adoption of hair care products.
The availability of many alternative hair loss treatment alternatives, such as laser hair therapy, hair transplant surgery, and light-based therapies, is expected to constrain the global hair loss treatment products market over the forecast period.
Covid-19 Impact on Hair Loss Treatment Products Market
In addition, the current Hair Loss Treatment Products Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Hair Loss Treatment Products Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Hair Loss Treatment Products Market Segment Overview
According to Product Type, Shampoos and Conditioners is the most prominent segment in the global Hair Loss Treatment Products Market. Supplements and Vitamins/ Medicine Product and Serum & oil, these are another main segment in the global market. Based on Disease Type, Alopecia Areata is one of the major segments in the global Hair Loss Treatment Products Market. Alopecia areata is a condition in which the immune system attacks hair follicles, which can be triggered by extreme stress. Hair loss is the most common symptom. Treatment may include topical scalp treatment to address any underlying conditions.
Hair Loss Treatment Products Market, By Product Type
· Shampoos and Conditioners
· Supplements and Vitamins/ Medicine Product
· Serum & oil
· Others
Hair Loss Treatment Products Market, By Disease Type
· Alopecia Areata
· Cicatricial Alopecia
· Traction Alopecia
· Others
Hair Loss Treatment Products Market, By Distribution Channel
· Hypermarkets and Supermarkets
· Medical/Pharmacy Stores
· E-commerce
· Others
Hair Loss Treatment Products Regional Overview
In terms of geography, the global Hair Loss Treatment Products Market is classified into North America, South America, Europe, Asia Pacific and Middle East & Africa. North America is expected to account for a leading share of the global hair loss treatment products market during the forecast period. This is due to an increase in patient population, increasing changes in lifestyle, increased hair loss, increasing ageing population, increased research & development activities, availability of well-established health care infrastructure, continuous technological advancements, rise in the number of well-equipped laboratories, and presence of key players.
Furthermore, due to the rising prevalence of hair loss, growing geriatric population, rising patient population, increasing awareness, expanding health care sector, and rising interest of key players in expanding their presence in the market in the Asia Pacific, the hair loss treatment products market is expected to grow at a rapid pace during the forecast period.
Hair Loss Treatment Products Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Hair Loss Treatment Products Market Competitor overview
Some key developments and strategies adopted by manufacturers in Hair Loss Treatment Products are highlighted below.
· In November 2023, Exicure, Inc., a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) technology, announced that Allergan’s wholly-owned subsidiary, Allergan Pharmaceuticals International Limited, and Exicure, Inc. have entered into a global collaboration agreement to discover and develop novel treatments for hair loss disorders based on Exicure’s proprietary SNA technology.
Hair Loss Treatment Products Market, Key Players
· Sun Pharmaceutical Industries Ltd.
· Aclaris Therapeutics, Inc.
· Concert Pharmaceuticals
· Daiichi Sankyo Company, Limited
· GlaxoSmithKline plc.
· HCell Inc.
· Histogen Inc.
· Merck & Co., Inc.
· Johnson & Johnson Services, Inc.
Baldness is a term that refers to a person's scalp losing a lot of hair. The most prevalent cause of baldness is hereditary hair loss as people become older. Some people would rather let their hair loss go unnoticed and untreated. Hair loss can be caused by a variety of factors, and it can also be treated in a variety of ways. Hair loss treatment treatments stop hair loss in its tracks and encourage hair growth.
The major factors driving the hair loss treatment market are changing lifestyle patterns, increasing stress levels due to the adoption of hectic schedules, which results in frequent hair loss at an earlier age among the young population, increasing disposable income, and increasing emphasis on appearance. Hair loss is caused by a variety of factors including heredity, excessive stress or shock to the body, toxic substances such as chemotherapy, radiation therapy, and some drugs, as well as medical disorders.
The global hair loss treatment products market is being boosted by rising demand for hair loss treatment products, an increase in patient population, an increase in research and development activities in health care, an increase in the geriatric population, and an increase in the adoption of hair care products.
The availability of many alternative hair loss treatment alternatives, such as laser hair therapy, hair transplant surgery, and light-based therapies, is expected to constrain the global hair loss treatment products market over the forecast period.
| Report Metric | Details |
| Market size available for years | 2023–2030 |
| Base year considered | 2023 |
| Forecast period | 2024–2030 |
| Forecast unit | Value (USD Million) |
| Segments covered | Product Type, Disease Type, Distribution Channel, and Region. |
| Regions covered | North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA) |
| Companies covered | Sun Pharmaceutical Industries Ltd., Aclaris Therapeutics, Inc., Concert Pharmaceuticals, Daiichi Sankyo Company, Limited, GlaxoSmithKline plc., HCell Inc., Histogen Inc., Merck & Co., Inc., Johnson & Johnson Services, Inc. |
Covid-19 Impact on Hair Loss Treatment Products Market
In addition, the current Hair Loss Treatment Products Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Hair Loss Treatment Products Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Hair Loss Treatment Products Market Segment Overview
According to Product Type, Shampoos and Conditioners is the most prominent segment in the global Hair Loss Treatment Products Market. Supplements and Vitamins/ Medicine Product and Serum & oil, these are another main segment in the global market. Based on Disease Type, Alopecia Areata is one of the major segments in the global Hair Loss Treatment Products Market. Alopecia areata is a condition in which the immune system attacks hair follicles, which can be triggered by extreme stress. Hair loss is the most common symptom. Treatment may include topical scalp treatment to address any underlying conditions.
Hair Loss Treatment Products Market, By Product Type
· Shampoos and Conditioners
· Supplements and Vitamins/ Medicine Product
· Serum & oil
· Others
Hair Loss Treatment Products Market, By Disease Type
· Alopecia Areata
· Cicatricial Alopecia
· Traction Alopecia
· Others
Hair Loss Treatment Products Market, By Distribution Channel
· Hypermarkets and Supermarkets
· Medical/Pharmacy Stores
· E-commerce
· Others
Hair Loss Treatment Products Regional Overview
In terms of geography, the global Hair Loss Treatment Products Market is classified into North America, South America, Europe, Asia Pacific and Middle East & Africa. North America is expected to account for a leading share of the global hair loss treatment products market during the forecast period. This is due to an increase in patient population, increasing changes in lifestyle, increased hair loss, increasing ageing population, increased research & development activities, availability of well-established health care infrastructure, continuous technological advancements, rise in the number of well-equipped laboratories, and presence of key players.
Furthermore, due to the rising prevalence of hair loss, growing geriatric population, rising patient population, increasing awareness, expanding health care sector, and rising interest of key players in expanding their presence in the market in the Asia Pacific, the hair loss treatment products market is expected to grow at a rapid pace during the forecast period.
Hair Loss Treatment Products Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Hair Loss Treatment Products Market Competitor overview
Some key developments and strategies adopted by manufacturers in Hair Loss Treatment Products are highlighted below.
· In November 2023, Exicure, Inc., a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) technology, announced that Allergan’s wholly-owned subsidiary, Allergan Pharmaceuticals International Limited, and Exicure, Inc. have entered into a global collaboration agreement to discover and develop novel treatments for hair loss disorders based on Exicure’s proprietary SNA technology.
Hair Loss Treatment Products Market, Key Players
· Sun Pharmaceutical Industries Ltd.
· Aclaris Therapeutics, Inc.
· Concert Pharmaceuticals
· Daiichi Sankyo Company, Limited
· GlaxoSmithKline plc.
· HCell Inc.
· Histogen Inc.
· Merck & Co., Inc.
· Johnson & Johnson Services, Inc.
Frequently Asked Questions (FAQ) :
Q1. What are the driving factors for the global Hair Loss Treatment Products market?
The global hair loss treatment products market is being boosted by rising demand for hair loss treatment products, an increase in patient population, an increase in research and development activities in health care etc
Q2. Which Segments are covered in the global Hair Loss Treatment Products market report?
Product Type, Disease Type, Distribution Channel, and Region. these segments are covered in the global Hair Loss Treatment Products market report
Q3. Which segment is projected to hold the largest share in the global Hair Loss Treatment Products market?
Shampoos and Conditioners segment is projected to hold the largest share in the global Hair Loss Treatment Products market
Q4. Which region holds the largest share in the global Hair Loss Treatment Products market?
North America holds the largest share in the global Hair Loss Treatment Products market
Q5. Which are the prominent players in the global Hair Loss Treatment Products market?
Sun Pharmaceutical Industries Ltd., Aclaris Therapeutics, Inc., Concert Pharmaceuticals, Daiichi Sankyo Company, Limited, GlaxoSmithKline plc., HCell Inc., Histogen Inc., Merck & Co., Inc., Johnson & Johnson Services, Inc. are some key players in the global Hair Loss Treatment Products market.
Hair Loss Treatment Products Market Study Global Market Analysis, Insights and Forecast, 2020-2027
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Hair Loss Treatment Products Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Product Type
- 5.2.1. Shampoos and Conditioners
- 5.2.2. Supplements and Vitamins/ Medicine Product
- 5.2.3. Serum & oil
- 5.2.4. Others
- 5.3. Market Analysis, Insights and Forecast – By Disease Type
- 5.3.1. Alopecia Areata
- 5.3.2. Cicatricial Alopecia
- 5.3.3. Traction Alopecia
- 5.3.4. Others
- 5.4. Market Analysis, Insights and Forecast – By Distribution Channel
- 5.4.1. Hypermarkets and Supermarkets
- 5.4.2. Medical/Pharmacy Stores
- 5.4.3. E-commerce
- 5.4.4. Others
- 5.5. Market Analysis, Insights and Forecast – By Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America, Middle East and Africa
6. North America Hair Loss Treatment Products Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Product Type
- 6.2.1. Shampoos and Conditioners
- 6.2.2. Supplements and Vitamins/ Medicine Product
- 6.2.3. Serum & oil
- 6.2.4. Others
- 6.3. Market Analysis, Insights and Forecast – By Disease Type
- 6.3.1. Alopecia Areata
- 6.3.2. Cicatricial Alopecia
- 6.3.3. Traction Alopecia
- 6.3.4. Others
- 6.4. Market Analysis, Insights and Forecast – By Distribution Channel
- 6.4.1. Hypermarkets and Supermarkets
- 6.4.2. Medical/Pharmacy Stores
- 6.4.3. E-commerce
- 6.4.4. Others
- 6.5. Market Analysis, Insights and Forecast – By Country
- 6.5.1. U.S.
- 6.5.2. Canada
7. Europe Hair Loss Treatment Products Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Product Type
- 7.2.1. Shampoos and Conditioners
- 7.2.2. Supplements and Vitamins/ Medicine Product
- 7.2.3. Serum & oil
- 7.2.4. Others
- 7.3. Market Analysis, Insights and Forecast – By Disease Type
- 7.3.1. Alopecia Areata
- 7.3.2. Cicatricial Alopecia
- 7.3.3. Traction Alopecia
- 7.3.4. Others
- 7.4. Market Analysis, Insights and Forecast – By Distribution Channel
- 7.4.1. Hypermarkets and Supermarkets
- 7.4.2. Medical/Pharmacy Stores
- 7.4.3. E-commerce
- 7.4.4. Others
- 7.5. Market Analysis, Insights and Forecast – By Country
- 7.5.1. UK
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Italy
- 7.5.5. Spain
- 7.5.6. Russia
- 7.5.7. Rest of Europe
8. Asia Pacific Hair Loss Treatment Products Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Product Type
- 8.2.1. Shampoos and Conditioners
- 8.2.2. Supplements and Vitamins/ Medicine Product
- 8.2.3. Serum & oil
- 8.2.4. Others
- 8.3. Market Analysis, Insights and Forecast – By Disease Type
- 8.3.1. Alopecia Areata
- 8.3.2. Cicatricial Alopecia
- 8.3.3. Traction Alopecia
- 8.3.4. Others
- 8.4. Market Analysis, Insights and Forecast – By Distribution Channel
- 8.4.1. Hypermarkets and Supermarkets
- 8.4.2. Medical/Pharmacy Stores
- 8.4.3. E-commerce
- 8.4.4. Others
- 8.5. Market Analysis, Insights and Forecast – By Country
- 8.5.1. China
- 8.5.2. India
- 8.5.3. Japan
- 8.5.4. Australia
- 8.5.5. South East Asia
- 8.5.6. Rest of Asia Pacific
9. Latin America, Middle East and Africa Hair Loss Treatment Products Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Product Type
- 9.2.1. Shampoos and Conditioners
- 9.2.2. Supplements and Vitamins/ Medicine Product
- 9.2.3. Serum & oil
- 9.2.4. Others
- 9.3. Market Analysis, Insights and Forecast – By Disease Type
- 9.3.1. Alopecia Areata
- 9.3.2. Cicatricial Alopecia
- 9.3.3. Traction Alopecia
- 9.3.4. Others
- 9.4. Market Analysis, Insights and Forecast – By Distribution Channel
- 9.4.1. Hypermarkets and Supermarkets
- 9.4.2. Medical/Pharmacy Stores
- 9.4.3. E-commerce
- 9.4.4. Others
- 9.5. Market Analysis, Insights and Forecast – By Country
- 9.5.1. Brazil
- 9.5.2. Saudi Arabia
- 9.5.3. UAE
- 9.5.4. Rest of LAMEA
10. Competitive Analysis
- 10.1. Company Market Share Analysis, 2018
- 10.2. Key Industry Developments
- 10.3. Company Profile
- 10.4. Sun Pharmaceutical Industries Ltd.
- 10.4.1. Business Overview
- 10.4.2. Segment 1 & Service Offering
- 10.4.3. Overall Revenue
- 10.4.4. Geographic Presence
- 10.4.5. Recent Development
- 10.5. Aclaris Therapeutics, Inc.
- 10.6. Concert Pharmaceuticals
- 10.7. Daiichi Sankyo Company, Limited
- 10.8. GlaxoSmithKline plc.
- 10.9. HCell Inc.
- 10.10. Histogen Inc.
- 10.11. Merck & Co., Inc.
Research Process
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
